GB Sciences Financials
| GBLX Stock | USD 0.0008 0.0001 11.11% |
GBLX |
Understanding current and past GB Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GB Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in GB Sciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in GB Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GB Sciences. Check GB Sciences' Beneish M Score to see the likelihood of GB Sciences' management manipulating its earnings.
GB Sciences Stock Summary
GB Sciences competes with Antibe Therapeutics, Scisparc, Cellectis, and Covalon Technologies. GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US3615441090 |
| Business Address | 3550 West Teco |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.gbsciences.com |
| Phone | 866 721 0297 |
| Currency | USD - US Dollar |
GB Sciences Key Financial Ratios
GB Sciences' financial ratios allow both analysts and investors to convert raw data from GB Sciences' financial statements into concise, actionable information that can be used to evaluate the performance of GB Sciences over time and compare it to other companies across industries.| Return On Equity | -50.98 | |||
| Return On Asset | -0.21 | |||
| Beta | 0.56 | |||
| Z Score | -30.0 |
GBLX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GB Sciences's current stock value. Our valuation model uses many indicators to compare GB Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GB Sciences competition to find correlations between indicators driving GB Sciences's intrinsic value. More Info.GB Sciences is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value GB Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GB Sciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.GB Sciences Systematic Risk
GB Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GB Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on GB Sciences correlated with the market. If Beta is less than 0 GB Sciences generally moves in the opposite direction as compared to the market. If GB Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GB Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GB Sciences is generally in the same direction as the market. If Beta > 1 GB Sciences moves generally in the same direction as, but more than the movement of the benchmark.
GB Sciences Thematic Clasifications
GB Sciences is part of Marijuana investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States
This theme covers Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. Get More Thematic Ideas
| Marijuana | View |
GB Sciences March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GB Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GB Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of GB Sciences based on widely used predictive technical indicators. In general, we focus on analyzing GBLX Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GB Sciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 30.98 | |||
| Information Ratio | 0.1338 | |||
| Maximum Drawdown | 488.0 | |||
| Value At Risk | (30.00) | |||
| Potential Upside | 50.0 |
Additional Tools for GBLX Pink Sheet Analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.